Oak Street Health gains as antitrust waiting period for CVS acquisition expired
Mar. 30, 2023 7:11 AM ETOak Street Health, Inc. (OSH), CVSBy: Joshua Fineman, SA News Editor2 Comments
Sundry Photography/iStock Editorial via Getty Images
- Oak Street Health (NYSE:OSH) rose 4.7% in premarket trading after disclosing that the antitrust waiting period for its planned sale to CVS Health (NYSE:CVS) expired on Monday.
- Oak Street (OSH) and CVS (CVS) filed the requisite notification forms under the HSR Act with the Dept. of Justice and the Federal Trade Commission on Feb. 24 and the waiting period under the HSR ACT expired on Monday, according to a proxy filing on Thursday.
- The filing comes after Sen. Elizabeth Warren (D-MA) earlier this month urged the FTC to closely scrutinize CVS Health's (CVS) proposed acquisition of the primary care company. Warren's letter came after CVS (CVS) agreed to acquire Oak Street Health (OSH) last month for ~$10.6 billion, or $39 a share.
- Oak Street (OSH) also announced on Thursday that it's cancelling its annual meeting following the CVS (CVS) deal, which is expected to close in the first half of the year.